Abstract
Sickle cell disease (SCD) is a prevalent genetic disorder that includes sickle cell anemia (hemoglobin SS), hemoglobin SC, and hemoglobin Sb-thalassemia. Patients with SCD present with a defective activation of the alternate pathway of the complement system that increases the risk of capsulate bacteria infection and failure to eliminate antigens, predisposing these patients to autoimmune diseases. The authors describe three patients with SCD that developed systemic lupus erythematosus (SLE). In all patients, SLE diagnosis was delayed because symptoms were initially attributable to SCD. Physicians should be alerted to the possible development of SLE in patients with SCD to not delay the diagnosis and start appropriate treatment.
Similar content being viewed by others
References
Almeida A, Roberts I (2005) Bone involvement in sickle cell disease. Br J Haematol 129:482–490
Omojola MF, Annobil S, Adzaku F, Addae SK, Mohammed S (1993) Bone changes in sickle cell anaemia. East Afr Med J 70:154–158
Johnston RB, Newman SL, Struth AG (1973) An abnormality of the alternative pathway of complement activation in sickle-cell anemia. N Engl J Med 288:803–808
Wilson WA, Hughes GRV, Lachmann PJ (1976) Deficiency of factor B of the complement system in sickle cell anemia. Br Med J 1:367–369
Koethe SM, Casper JT, Rodey GE (1976) Alternative pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol 23:56–60
Corry JM, Polhill RB, Edmons SR et al (1979) Activity of the alternate complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr 95:964
Wilson WA, Deceulaer K, Morgan AG (1979) Sickle cell anemia, complement and systemic lupus erythematosus. Arthritis Rheum 22:803
Saxena VR, Mina R, Moallem HJ, Rao SP, Miller ST (2003) Systemic lupus erythematosus in children with sickle cell disease. J Pediatr Hematol Oncol 25:668–671
Khalidi NA, Ajmani H, Varga J (2005) Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge. J Clin Rheumatol 11:86–92
Shetty AK, Kumar SR, Gedalia A et al (1998) Sickle cell anemia with systemic lupus erythematosus: response to hydroxyurea therapy. J Pediatr Hematol Oncol 20:335–337
Eissa MM, Lawrence JM 3rd, McKenzie L et al (1995) Systemic lupus erythematosus in a child with sickle cell disease. South Med J 88:1176–1178
Katsanis E, Hsu E, Luke KH et al (1987) Systemic lupus erythematosus and sickle hemoglobinopathies: a report of two cases and review of the literature. Am J Hematol 25:211–214
Wilson WA, Nicholson GD, Hughes GRV et al (1976) Systemic lupus erythematosus and sickle cell anaemia. Br Med J 1:813
Karthikeyan G, Wallace SL, Blum L (1978) SLE and sickle cell disease. Arthritis Rheum 21:862–863
Luban NLC, Boeckx R, Barr O (1980) Sickle cell anemia and SLE. J Pediatr 96:1120
Warrier RP, Sahney S, Walker H (1984) Hemoglobin sickle cell disease and systemic lupus erythematosus. J Natl Med Assoc 76:1030–1031
White LE, Reeves JD (1979) Polyarthritis and positive LE preparation in sickle hemoglobinopathies: a report of two cases. J Pediatr 95:1003–1004
Shaw HE, Osher RH, Smith JL (1979) Amaurosis fugax associated with SC hemoglobinopathy and lupus erythematosus. Am J Opthalmol 87:281–285
Hochberg M (1997) American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 39:403–404
Tan EM, Cohen AS, Fries et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Baethge BA, Bordelon TR, Mills GM, Bowen LM, Wolf RE, Bairnsfather L (1990) Antinuclear antibodies in sickle cell disease. Acta Haematol 84:186–189
Madani G, Papadopoulou AM, Holloway B, Robins A, Davis J, Murray D (2007) The radiological manifestations of sickle cell disease. Clin Radiol 62:528–538
Lonergan GJ, Cline DB, Abbondanzo SL (2001) Sickle cell anemia. Radiographics 21:971–994
Kim SK, Miller JH (2002) Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies. J Nucl Med 43:896–900
Almeida A, Roberts I (2005) Bone involvement in sickle cell disease. Br J Haematol 129:482–490
Smith JA (1996) Bone disorders in sickle cell disease. Hematol/Oncol Clin North Am 10:1345–1356
Pham PT, Lew SQ, Balow JE (1997) Sickle cell nephropathy during the postpartum period with SLE. Am J Kidney Dis 30:879–883
Powars DR, Elliott-Mills DD, Chan L et al (1991) Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Int Med 115:614–620
Falk RJ, Jennette JC (1994) Sickle cell nephropathy. Adv Nephrology 23:133–147
Wigfall DR, Ware RE, Burchinal MR et al (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749–753
Nasr SH, Markowitz GS, Sentman RL, D’Agati VD (2006) Sickle cell disease, nephrotic syndrome, and renal failure. Kidney Int 69:1276–1280
Hulbert ML, Scothorn DJ, Panepinto JA et al (2006) Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 149:710–712
Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF (2006) Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 118:1916–1924
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Appenzeller, S., Fattori, A., Saad, S.T. et al. Systemic lupus erythematosus in patients with sickle cell disease. Clin Rheumatol 27, 359–364 (2008). https://doi.org/10.1007/s10067-007-0779-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0779-7